[1] Wang ZY, Chen Z. Acute promyelocytic leukemia:from highly fatal to highly curable[J] .Blood, 2008, 111(5) :2505-2515. [2] Tarhini AA, Kirkwood JM, Tawbi H, et al. Safety and efficacy of arsenic trioxide for patientswith advanced met-astatic melanoma[J] .Cancer, 2008, 112(5) :1131 -1138. [3] Amarante-Mendes GP, McGahon AJ, Nishioka WK, et al. Bcl-2-independent Bcr-Abl-mediated resistance to ap-optosis:protection is correlated with up regulation of Bcl-xL[J] .Oncogene, 1998, 16(11) :1383-1390. [4] 刘新建.三氧化二砷联合伊马替尼治疗慢性粒细胞白血病急变期五例[J] .白血病·淋巴瘤, 2006, 15(4) :285-286. [5] Asakura T, Maeda K, Omi H, et al. The association of deamidationof Bcl -xL and translocation of Bax to the mito-chondria through activation of JNK in the induction of ap-optosis by treatment with GSH-conjugated DXR[J] .Int J Oncol, 2008, 33(2) :389-395.
[6] 章圣辉, 韩义香, 尹丽慧, 等.三氧化二砷诱导 K562细胞凋亡与其抑制 Evi-1 表达有关[J] .癌变.畸变.突变, 2006, 18(4) :323-326. [7] 章圣辉, 俞康, 吴建波, 等.苦参碱诱导 RPMI8226 细胞凋亡及其对 Bcl-2、增殖细胞核抗原蛋白表达的影响[J] .中国临床药理学与治疗学, 2007, 12(5) :566-570. [8] Chen YR, Tan TH. The c-jun N-Terminal kinase pathway and apoptotic signaling[J] .Int J Oncol, 2000, 16(4) :651-662. [9] Chen TH, Pan SL, Guh JH, et al. Moscatilininduces ap-optosis in human colorectal cancer cells:a crucial role of c-Jun NH2-terminal protein kinase activation caused by tubulin depolymerization and DNA damage[J] .Clin Can-cer Res, 2008, 14(13) :4250-4258. [10] Liebermann DA, Hoffman B, Vesely D. p53 induced growth arrest versus apoptosis and its modulation by sur-vival cytokines[J] .Cell Cycle, 2007, 6(2) :166-170. [11] Mitani S, Kamata H, Fujiwara M, et al. Missense muta-tion with without nonsense mutation of the p53gene is as-sociated with large cell morphology in human malignant lymphoma[J] .Pathol Int, 2007, 57(7) :430-436. [12] Alsner J, Jensen V, Kyndi M, et al. A comparison be-tween p53 accumulation determined by immunohistoche-mistry and TP53 mutations as prognostic variables in tu-mours from breast cancer patients[J] .Acta Oncol, 2008,47(4) :600-607. |